Related Experiment Videos
Isolating ligands specific for human vasculature using in vivo phage selection
Andrew J T George1, Lewis Lee, Costantino Pitzalis
1Department of Immunology, Division of Medicine, Imperial College London, Hammersmith Hospital, UK. a.george@imperial.ac.uk
Trends in Biotechnology
|May 3, 2003
Summary
Identifying tissue-specific molecules on blood vessels is challenging. In vivo phage selection in xenograft models successfully isolated peptides targeting human vasculature, offering new therapeutic and diagnostic potential.
Area of Science:
- Vascular Biology
- Molecular Targeting
- Biotechnology
Background:
- Endothelium expresses tissue-specific molecules, ideal for targeted therapies.
- Identifying these molecules is difficult as endothelial cells lose specificity ex vivo.
- Targeting specific blood vessels offers precise delivery for therapies and diagnostics.
Purpose of the Study:
- To overcome challenges in identifying tissue-specific endothelial molecules.
- To develop a method for isolating agents that target specific human vasculature.
- To explore the potential of in vivo phage selection for vascular targeting.
Main Methods:
- Utilized in vivo phage selection by injecting phage libraries into animals.
- Employed a variation involving animals bearing human tissue xenografts.
- Isolated phage displaying peptides that bind to specific tissues in vivo.
Main Results:
- Successfully isolated peptides specific for human vasculature using xenografts.
- Demonstrated the efficacy of in vivo phage selection for identifying tissue-specific vascular targets.
- Confirmed the ability to find molecules targeting human blood vessels within a complex biological system.
Conclusions:
- In vivo phage selection in xenograft models is effective for discovering vascular-specific targets.
- This approach enables the identification of molecules for targeted therapy and diagnosis.
- The findings open new avenues for developing treatments that precisely reach desired tissues via their vasculature.